Dr Sam Hollingworth

Senior Lecturer

School of Pharmacy
Faculty of Health and Behavioural Sciences
s.hollingworth@uq.edu.au
+61 7 334 61981

Overview

Sam is an academic at the School of Pharmacy at the University of Queensland. She has an honorary appointment at Imperial College London (sabbatical in 2018). Her research focuses on medicines and health systems. She works with an extensive network of clinicians and health professionals to investigate the use of medicines and adverse effects in cancer, psychiatry, neurology, internal medicine, and general practice. Sam works on economic evaluations and health technology assessment (HTA). She has an active interest in health systems and health services research, with a particular focus on low and middle-income countries (LMIC) and non-communicable diseases (NCD).

Sam coordinates, lectures, and tutors in the BPharm(Hons) program, has taight at postgradtuate level, and is an advisor on diverse PhD projects. Sam has studied and worked in Brisbane (UQ), Melbourne (Monash), Toronto (Mt Sinai Hospital), and Kumasi, Ghana (Kwame Nkrumah University of Science and Technology). Sam worked as a consultant in HTA in Australia for many years evaluating submissions to subsidise medicines on the Pharmaceutical Benefits Scheme (PBS). She has worked on international health projects in Indonesia and is currently working on several HTA projects in Ghana.

Research Interests

  • Health technology assessment (HTA) and decision-making
    Working with partners in low and middle income countries to manage and allocate their finite resources to ensure their healthcare systems meet the need for universal healthcare coverage efficiently and equitably
  • Economic evaluations within health care and evidence-based practice
    Critically appraising the quality of evidence and ‘value for money’ of medicines and health services
  • Use of medicines in populations (pharmacoepidemiology)
    Exploring the use of medicines and their side effects using routinely collected data and describing the ‘real world’ effectiveness of medicines (e.g. in cancer)
  • Health systems, services, and medicines in non-communicable diseases
    Describing the use of medicines and other health services to treat non-communicable diseases (NCDs) with a focus on low and middle income countries

Qualifications

  • Bachelor of Science, The University of Queensland
  • Master of Public Health, The University of Queensland
  • PhD, Monash University
  • Bachelor of Science(hons), The University of Queensland

Publications

  • Hollingworth, Samantha A., Lie, David C., Siskind, Dan J., Byrne, Gerard J., Hall, Wayne D. and Whiteford, Harvey A. (2011) Psychiatric drug prescribing in elderly Australians: Time for action. Australian And New Zealand Journal of Psychiatry, 45 9: 705-708. doi:10.3109/00048674.2011.594947

  • Hollingworth, Samantha A., Nissen, Lisa M., Stathis, Stephen S., Siskind, Dan J., Varghese, John M. N. and Scott, James G. (2011) Australian national trends in stimulant dispensing: 2002-2009. Australian and New Zealand Journal of Psychiatry, 45 4: 332-336. doi:10.3109/00048674.2010.543413

  • Hollingworth, Samantha A., Rush, Amanda, Hall, Wayne D. and Eadie, Mervyn J. (2011) Utilization of anti-Parkinson drugs in Australia: 1995–2009. Pharmacoepidemiology and Drug Safety, 20 5: 450-456. doi:10.1002/pds.2114

  • Hollingworth, Samantha A., Siskind, Dan J., Nissen, Lisa M., Robinson, Maxine and Hall, Wayne D. (2010) Patterns of antipsychotic medication use in Australia 2002-2007. Australian And New Zealand Journal of Psychiatry, 44 4: 372-377. doi:10.3109/00048670903489890

  • Hollingworth, SA and Siskind, DJ (2010) Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiology and Drug Safety, 19 3: 280-288. doi:10.1002/pds.1899

View all Publications

Supervision

View all Supervision

Available Projects

  • How are medicines used in the real world after registration and public subsidy? Are we using them in the most effective way possible? We can use routinely collected data to investigate the use of medicines and their side effects in populations.

  • How do we decide which health services and medicines to use in our health systems? Health Technology Assessment (HTA, including economic evaluations) is a tool to help answer the questions: does it work and is it good value for money? I work with an international consortium and partners in Ghana to help them manage and allocate their finite resources to ensure their healthcare systems meet the need for universal healthcare coverage efficiently and equitably.

View all Available Projects

Publications

Featured Publications

Book

Book Chapter

  • del Mar, Chris, Bennett, Sally, Abell, Bridgett, Boyle, Malcolm, Hill, Kylie, Hollingworth, Samantha, Lewis, Courtney, Noffs, Gustavo, Rickard, Claire, Sanders, Sharon, Schneider, Michal, Stedeman, Inge and Vogel, Adam (2017). Questions about diagnosis: examples of appraisals from different health professions. In Tammy Hoffmann, Sally Bennett and Chris Del Mar (Ed.), Evidence-based practice across the health professions Third edition ed. (pp. 159-184) Chatswood, NSW, Australia: Elsevier.

Journal Article

Conference Publication

Other Outputs

Grants (Administered at UQ)

PhD and MPhil Supervision

Current Supervision

  • Doctor Philosophy — Principal Advisor

  • Doctor Philosophy — Principal Advisor

    Other advisors:

  • Doctor Philosophy — Associate Advisor

    Other advisors:

  • Doctor Philosophy — Associate Advisor

    Other advisors:

Possible Research Projects

Note for students: The possible research projects listed on this page may not be comprehensive or up to date. Always feel free to contact the staff for more information, and also with your own research ideas.

  • How are medicines used in the real world after registration and public subsidy? Are we using them in the most effective way possible? We can use routinely collected data to investigate the use of medicines and their side effects in populations.

  • How do we decide which health services and medicines to use in our health systems? Health Technology Assessment (HTA, including economic evaluations) is a tool to help answer the questions: does it work and is it good value for money? I work with an international consortium and partners in Ghana to help them manage and allocate their finite resources to ensure their healthcare systems meet the need for universal healthcare coverage efficiently and equitably.